GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,697 | -52.5% | 24,986 | -31.1% | 0.00% | – |
| Q2 2023 | $199,315 | -43.8% | 36,239 | -56.1% | 0.00% | – |
| Q1 2023 | $354,832 | -60.2% | 82,519 | -63.6% | 0.00% | -100.0% |
| Q4 2022 | $891,513 | -22.7% | 226,848 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $1,154,000 | -3.4% | 217,417 | +19.5% | 0.00% | 0.0% |
| Q2 2022 | $1,194,000 | -28.2% | 182,004 | -19.7% | 0.00% | -50.0% |
| Q1 2022 | $1,663,000 | +46.4% | 226,601 | +41.3% | 0.00% | +100.0% |
| Q4 2021 | $1,136,000 | +441.0% | 160,387 | +1818.7% | 0.00% | – |
| Q3 2021 | $210,000 | -93.8% | 8,359 | -93.3% | 0.00% | -100.0% |
| Q2 2021 | $3,367,000 | -11.7% | 125,150 | -6.6% | 0.00% | -25.0% |
| Q1 2021 | $3,815,000 | +722.2% | 134,060 | +719.8% | 0.00% | – |
| Q4 2020 | $464,000 | – | 16,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |